Halozyme

FDA Updates PDUFA Date of BLA for Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
Onc Live
Tue, 05/21/24 - 07:15 pm
FDA
Bristol Myers Squibb
Opdivo
Halozyme
solid tumors
BMS, Halozyme score with subcutaneous version of Opdivo
Fierce Pharma
Thu, 10/19/23 - 10:42 pm
Bristol Myers Squibb
Halozyme
Opdivo
clinical trials
Roche hits FDA delay with subcutaneous version of Tecentriq amid manufacturing process changes
Fierce Pharma
Thu, 09/7/23 - 10:53 pm
Roche
FDA
Tecentriq
Halozyme
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
injectables
cancer
JNJ
Bristol Myers Squibb
Halozyme
drug pricing
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
pharma stocks
Merck
Eli Lilly
AbbVie
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Sarepta Therapeutics
Halozyme
Horizon Therapeutics
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
The Big Winner With Johnson & Johnson's Recent FDA Approval
Motley Fool
Fri, 07/23/21 - 10:53 am
JNJ
FDA
Darzalex Faspro
Halozyme
Pair of R&D updates bolster GSK ahead of investor meeting
Pharmaforum
Tue, 06/22/21 - 10:52 am
GSK
COVID-19
sotrovimab
Halozyme
investors
J&J’s next-gen Darzalex sparks drug delivery royalties battle
Fierce Pharma
Thu, 09/24/20 - 11:32 pm
JNJ
Darzalex
Genmab
Halozyme
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020
Xconomy
Tue, 01/21/20 - 11:40 pm
Halozyme
clinical trials
drug delivery
Enhanze
Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3
Fierce Biotech
Tue, 11/27/18 - 11:35 pm
Halozyme
clinical trials
PEGPH20
metastatic prostate cancer
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Motley Fool
Sat, 09/16/17 - 12:05 pm
Halozyme
Inovalon
Teva Pharmaceutical
Unitedhealthcare Group
Roche
Bristol-Myers Squibb
Bristol To Pay Halozyme $105 Million To Make New Cancer Drugs Easier To Take
Forbes
Thu, 09/14/17 - 09:58 am
Bristol-Myers Squibb
Halozyme
Opdivo
Halozyme Cancer Drug Does Well in Phase 2
Investopedia
Fri, 01/6/17 - 10:13 am
Halozyme
pancreatic cancer
clinical trials
PEGPH20
Eli Lilly
Celgene
gemcitabine
Abraxane
AbbVie Ends Halozyme Development Deal
Investopedia
Tue, 11/22/16 - 09:43 pm
AbbVie
Halozyme
tnf-alpha
drug development
drug delivery
Halozyme shares drop after AbbVie punts a failed program; Celgene buys another cancer drug
Endpoints
Mon, 11/21/16 - 11:27 am
Halozyme
AbbVie
Celgene
marizomib
Halozyme Therapeutics reports 3Q loss
Yahoo/AP
Mon, 11/7/16 - 09:24 pm
earnings
Halozyme
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Yahoo
Fri, 11/4/16 - 09:18 am
FDA
Genentech
Halozyme
rituximab
blood cancer
3 Top Biopharma Movers of the Past Week
24/7 Wall St
Sun, 03/6/16 - 11:31 am
Vitae
Juno Therapeutics
Halozyme
Halozyme Therapeutics beats 4Q profit forecasts
Yahoo/AP
Mon, 02/29/16 - 11:58 pm
Halozyme
earnings

Pages